| Pubmed ID |
Author | Year | Title |
21324454 |
Niccoli G | 2011 | CD4+CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome. |
21325046 |
Hogg K | 2011 | Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. |
21325466 |
Tfayli H | 2011 | Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. |
21325745 |
Koiou E | 2011 | The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. |
21328294 |
Moran LJ | 2011 | Lifestyle changes in women with polycystic ovary syndrome. |
21329419 |
Naka KK | 2011 | Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study. |
21331030 |
Birnbaum MJ | 2011 | Genomics: Drugs, diabetes and cancer. |
21332919 |
Zainab J | 2011 | Laser hair removal in a patient with polycystic ovarian syndrome and vitiligo. |
21333983 |
Ganie MA | 2011 | Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. |
21335359 |
de Groot PC | 2011 | PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. |
21339935 |
Badawy A | 2011 | Treatment options for polycystic ovary syndrome. |
21352077 |
de Sousa G | 2011 | A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome. |
21353371 |
Katsikis I | 2011 | Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. |
21353671 |
Jungheim ES | 2011 | Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization. |
21353673 |
Kucherov A | 2011 | Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women. |
21355294 |
Zhang F | 2011 | [The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome]. |
21357181 |
Crete J | 2011 | Managing polycystic ovary syndrome: what our patients are telling us. |
21358414 |
Schlaich MP | 2011 | Renal denervation: a potential new treatment modality for polycystic ovary syndrome? |
21362574 |
Glueck CJ | 2011 | Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. |
21366130 |
Coksuer H | 2011 | Effects of hyperandrogenism on tear function and tear drainage in patients with polycystic ovary syndrome. |
21366813 |
Brufani C | 2011 | Use of metformin in pediatric age. |
21372710 |
Lalioti MD | 2011 | Impact of follicle stimulating hormone receptor variants in fertility. |
21374548 |
Bals-Pratsch M | 2011 | Early onset and high prevalence of gestational diabetes in PCOS and insulin resistant women before and after assisted reproduction. |
21374929 |
Visnovsk? J | 2010 | [Hormonal treatment effectivity in hyperandrogenic syndrome]. |
21375143 |
Unfer V | 2010 | Polycystic ovary syndrome: a vitamin deficiency? Floating a new pathogenesis hypothesis. |
21376483 |
Kang HS | 2011 | The use of acupuncture for managing gynaecologic conditions: An overview of systematic reviews. |
21385417 |
Egan N | 2011 | Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS). |
21385809 |
Dyer C | 2011 | Doctor who injected her sister with unlicensed drug is struck off register. |
21388855 |
Robin G | 2011 | [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?]. |
21389086 |
Wehr E | 2011 | Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. |
21391350 |
Praz?kov? S | 2010 | [(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome]. |
21391472 |
Wassell J | 2011 | The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS). |
21393897 |
Bhutoria S | 2011 | Embryonal rhabdomyosarcoma of the adult soft palate. |
21398041 |
Ruta L | 2011 | Increased serum androstenedione in adults with autism spectrum conditions. |
21400443 |
Greenblatt EM | 1995 | Laparoscopic ovarian cautery for polycystic ovarian syndrome. |
21401530 |
Battaglia C | 2011 | Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome. |
21403408 |
Muderris II | 2011 | Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism. |
21406133 |
Bhattacharya S | 2010 | Female infertility. |
21406446 |
Dolfing JG | 2011 | Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. |
21411410 |
Cekmez F | 2011 | Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. |
21411543 |
Savaris RF | 2011 | Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. |
21411746 |
Hatzirodos N | 2011 | Linkage of regulators of TGF-? activity in the fetal ovary to polycystic ovary syndrome. |
21413876 |
Kilicci C | 2011 | Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome. |
21413894 |
Hillman JB | 2011 | Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. |
21415709 |
Nazli Y | 2011 | Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report. |
21417594 |
Minozzi M | 2011 | The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. |
21417649 |
Herlihy AC | 2011 | Polycystic ovary syndrome and the peripheral blood white cell count. |
21417650 |
Ozgun MT | 2011 | The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome. |
21418035 |
Economou F | 2011 | The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond. |
21418339 |
Sheppard KM | 2011 | Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe. |
21419313 |
Toscani MK | 2011 | Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome. |
21419406 |
Lecke SB | 2011 | Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. |
21419463 |
Morrison JA | 2011 | Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years. |
21419674 |
Ornstein RM | 2011 | Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. |
21421016 |
Barry JA | 2011 | The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controls. |
21424395 |
Villa J | 2011 | Adipose tissue dysfunction in polycystic ovary syndrome. |
21426455 |
Lipton RB | 2011 | Onset features and subsequent clinical evolution of childhood diabetes over several years. |
21427116 |
Hudecova M | 2011 | Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up. |
21427877 |
Kedikova S | 2010 | [Adolescent PCOS]. |
21429814 |
Zitsman JL | 2011 | Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adults. |
21429962 |
Radavelli-Bagatini S | 2011 | The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function. |
21434483 |
Papaleo E | 2011 | Myo-inositol products in polycystic ovary syndrome (PCOS) treatment: quality, labeling accuracy, and cost comparison. |
21435276 |
Tehrani FR | 2011 | The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. |
21436137 |
Deeks AA | 2011 | Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? |
21437531 |
Moura HH | 2011 | Polycystic ovary syndrome: a dermatologic approach. |
21437624 |
Gomes VA | 2011 | Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome. |
21437823 |
Catenacci M | 2011 | Transvaginal hydrolaparoscopy. |
21437828 |
Flyckt RL | 2011 | Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. |
21444075 |
Ewens KG | 2011 | Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. |
21446991 |
Ott J | 2011 | A modified technique of laparoscopic ovarian drilling for polycystic ovary syndrome using the monopolar hook electrode. |
21447274 |
Lebkowska A | 2010 | [Polycystic ovary syndrome in type 1 diabetes]. |
21447694 |
Amato MC | 2011 | The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. |
21448847 |
Mlinar B | 2011 | Lipin 1 gene polymorphisms in polycystic ovary syndrome. |
21450287 |
Hart R | 2011 | Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. |
21450291 |
Karakas S | 2011 | In search of the LINK: Acute Phase Serum Amyloid A. |
21450988 |
Puurunen J | 2011 | Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. |
21453749 |
Repaci A | 2011 | Ghrelin and reproductive disorders. |
21454179 |
Petr?nyi G | 2011 | [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome]. |
21454403 |
Carbajal L | 2011 | GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary. |
21454995 |
Al-Mutairi N | 2011 | Associated cutaneous diseases in obese adult patients: a prospective study from a skin referral care center. |
21457973 |
Abdellah MS | 2011 | Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. |
21458334 |
Altu? ?en T | 2011 | Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity. |
21463430 |
Coksuer H | 2011 | Evaluation of carotid wall thickness and vertebro-basilar system insufficiency in patients with obese polycystic ovary syndrome. |
21466513 |
Johnson N | 2011 | Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. |
21467073 |
Wang X | 2011 | Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. |
21468515 |
Marcondes JA | 2011 | [Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome]. |
21470277 |
Lee VC | 2011 | Aromatase inhibitors for ovulation induction and ovarian stimulation. |
21470992 |
Wehr E | 2011 | The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. |
21471855 |
Vitonis AF | 2011 | Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. |
21473679 |
Barry JA | 2011 | Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. |
21474127 |
Gonz?lez-Fern?ndez R | 2011 | Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways. |
21474465 |
Daskalopoulos GN | 2011 | Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome? |
21474907 |
Tao M | 2011 | Continuous glucose monitoring reveals abnormal features of postprandial glycemic excursions in women with polycystic ovarian syndrome. |
21474908 |
Li C | 2011 | Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome. |
21475046 |
Lembo G | 2011 | A lesson from polycystic ovarian syndrome: untangling the role of renal sympathetic nervous system on hypertension and insulin resistance. |
21475454 |
Omran MY | 2007 | Metformin and polycystic ovary syndrome. |
21477021 |
Baba T | 2011 | Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan. |
21477915 |
Honnma H | 2011 | Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports. |
21478180 |
Hickey M | 2011 | Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. |
21478181 |
Lindholm A | 2011 | No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. |
Showing 9,401–9,500 of 14,368